The Challenge
Genmab retained PharmaBioSource Realty as its exclusive real estate broker to divest its 215,000-square-foot mammalian cell culture biologics drug substance facility near Minneapolis, Minnesota. The facility housed 2 x 20,000L and 2 x 1,000L bioreactors with associated downstream suites, QC laboratories, offices, and GMP warehouse space.
The Solution
PharmaBioSource Realty marketed the facility to strategic acquirers.
Services provided by the PharmaBioSource Realty team:
- Benchmark valuation
- Buyer target identification
- Creation of the Confidential Information Memorandum (CIM)
- Data room development
- Due diligence support
- Negotiations and closing support
The Results
PharmaBioSource Realty identified Baxter as the acquirer of the Brooklyn Park facility.
What We Did
Real Estate Brokerage
Facility Divestiture